AI assistant
NEKTAR THERAPEUTICS — Director's Dealing 2017
Feb 6, 2017
32134_dirs_2017-02-06_b7f896e5-b366-462b-a662-d1a6d7551351.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NEKTAR THERAPEUTICS (NKTR)
CIK: 0000906709
Period of Report: 2017-02-02
Reporting Person: Nicholson John (SVP & Chief Operating Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-02-02 | Common Stock | M | 66495 | $4.65 | Acquired | 206821 | Direct |
| 2017-02-02 | Common Stock | S | 66495 | $12.38 | Disposed | 140326 | Direct |
| 2017-02-03 | Common Stock | M | 8505 | $4.65 | Acquired | 148831 | Direct |
| 2017-02-03 | Common Stock | S | 8505 | $12.48 | Disposed | 140326 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-02-02 | Employee Stock Option (right to buy) | $4.65 | M | 66495 | Disposed | 2017-02-22 | Common Stock (66495) | Direct |
| 2017-02-03 | Employee Stock Option (right to buy) | $4.65 | M | 8505 | Disposed | 2017-02-22 | Common Stock (8505) | Direct |
Footnotes
F1: The Reporting Person exercised and sold a portion of the Shares of common stock subject to this stock option that expires on February 22, 2017, with the objective of using substantially all of the proceeds to cover the exercise price of the entire stock option and applicable withholding taxes.
F2: This price reflects the weighted average sale price for open-market sales of Shares made by the Reporting Person on February 2, 2017. The actual prices for these transactions range from $12.20 to $12.45, inclusive. The Reporting Person further undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4.
F3: This price reflects the weighted average sale price for open-market sales of Shares made by the Reporting Person on February 3, 2017. The actual prices for these transactions range from $12.45 to $12.51, inclusive.
F4: This stock option became fully vested on February 23, 2013 and will expire on February 22, 2017 if not exercised.